Recurrent
Malignant Mesothelioma
Treatment
of recurrent mesothelioma usually utilizes procedures
and/or agents not previously employed in the initial
treatment attempt. No standard treatment approaches have
been proven to improve survival or control symptoms for
a prolonged period of time. These patients should be
considered candidates for phase I and II clinical trials
evaluating new biologicals, chemotherapeutic agents, or
physical approaches.[1-5]
Information about ongoing clinical trials is available
from the NCI Cancer.gov
Web site.
References
- Rusch
V, Saltz L, Venkatraman E, et al.: A phase II trial
of pleurectomy/decortication followed by
intrapleural and systemic chemotherapy for malignant
pleural mesothelioma. J Clin Oncol 12 (6): 1156-63,
1994. [PUBMED
Abstract]
- Markman
M, Kelsen D: Efficacy of cisplatin-based
intraperitoneal chemotherapy as treatment of
malignant peritoneal mesothelioma. J Cancer Res Clin
Oncol 118 (7): 547-50, 1992. [PUBMED
Abstract]
- Weissmann
LB, Antman KH: Incidence, presentation and promising
new treatments for malignant mesothelioma. Oncology
(Huntingt) 3 (1): 67-72; discussion 73-4, 77, 1989.
[PUBMED
Abstract]
- Boutin
C, Viallat JR, Van Zandwijk N, et al.: Activity of
intrapleural recombinant gamma-interferon in
malignant mesothelioma. Cancer 67 (8): 2033-7, 1991.
[PUBMED
Abstract]
- Ong
ST, Vogelzang NJ: Chemotherapy in malignant pleural
mesothelioma. A review. J Clin Oncol 14 (3):
1007-17, 1996. [PUBMED
Abstract]
# # #
Sources of National Cancer Institute Information
Mesothilioma, Mesotheliema,Mesothiliema,Mesotheleoma
Mesosthelioma, Masesthilioma information: |
|